Jeremy Findlay
Overview
Explore the profile of Jeremy Findlay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Virdee J, Saro G, Fouillet A, Findlay J, Ferreira F, Eversden S, et al.
Sci Rep
. 2017 Nov;
7(1):14498.
PMID: 29101377
Loss of synapses or alteration of synaptic activity is associated with cognitive impairment observed in a number of psychiatric and neurological disorders, such as schizophrenia and Alzheimer's disease. Therefore successful...
2.
Jambrina E, Cerne R, Smith E, Scampavia L, Cuadrado M, Findlay J, et al.
J Biomol Screen
. 2016 Feb;
21(5):468-79.
PMID: 26838761
N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors that play an important role in synaptic plasticity and learning and memory formation. Malfunctioning of NMDARs, in particular the reduction in NMDAR activity,...
3.
Bueno A, Gilmore J, Boot J, Broadmore R, Cooper J, Findlay J, et al.
Bioorg Med Chem Lett
. 2007 Apr;
17(12):3344-8.
PMID: 17434731
SAR around a known molecule with dual 5-HT(1D) antagonist and 5-HT(transporter) inhibitory activity has led to the discovery of molecules with improved dual activity and reduced cross-reactivity toward other aminergic...
4.
Cases-Thomas M, Masters J, Walter M, Campbell G, Haughton L, Gallagher P, et al.
Bioorg Med Chem Lett
. 2006 Jan;
16(7):2022-5.
PMID: 16413778
A novel series of tertiary alcohol containing 2-substituted benzyl morpholines have been discovered as potent and selective inhibitors of the norepinephrine transporter. Efficient synthetic routes were developed featuring a highly...
5.
Beadle C, Boot J, Camp N, Dezutter N, Findlay J, Hayhurst L, et al.
Bioorg Med Chem Lett
. 2005 Sep;
15(20):4432-7.
PMID: 16137883
A novel series of 1-aryl-3,4-dihydro-1H-quinolin-2-ones have been discovered as potent and selective norepinephrine reuptake inhibitors. Efficient synthetic routes have been developed which allow for the multi-gram preparation of both final...
6.
Boot J, Cases M, Clark B, Findlay J, Gallagher P, Hayhurst L, et al.
Bioorg Med Chem Lett
. 2005 Jan;
15(3):699-703.
PMID: 15664840
Novel arylthiomethyl morpholines are potent selective norepinephrine reuptake inhibitors (NERIs) and dual serotonin/norepinephrine reuptake inhibitors (SRI/NERIs). The target compounds were prepared using a stereochemically versatile synthesis featuring an aldol condensation...
7.
Torrado A, Lamas C, Agejas J, Jimenez A, Diaz N, Gilmore J, et al.
Bioorg Med Chem
. 2004 Sep;
12(20):5277-95.
PMID: 15388156
A series of compounds combining the naphthylpiperazine and thienopyran scaffolds has been prepared and evaluated for 5-HT reuptake inhibition with 5-HT1D antagonist activity. The design of these compounds has been...